Results 181 to 190 of about 196,164 (338)

Additional file 1: of Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

, 2015
Luisa Lindenberg, Lydia Spengler, Holger Bang, Thomas E. Dorner, Aleksej Maslyanskiy, С. В. Лапин, Е. П. Иливанова, Lorena Martinez‐Gamboa, H. Bastian, Esther Wittenborn, Karl Egerer, G.-R. Burmester, Eugen Feist   +12 more
openalex   +1 more source

Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma? [PDF]

, 2015
Heidi Móciková, Robert Pytlík, Pavla Štěpánková, Jozef Michalka, Jana Marková, Jan Kořen, Lucie Burešová, Luděk Raida, Zdeněk Král   +8 more
openalex   +1 more source

Rituximab-Induced Esophageal Ulcers and Strictures Presenting as Dysphagia. [PDF]

ACG Case Rep J
Abdulrazzak MA, Swied MY, Daaboul O, Azzawi M, Swied AM.   +4 more
europepmc   +1 more source

Cost-Effectiveness of First-Line Zuberitamab-CHOP versus Rituximab-CHOP Regimens in Untreated CD20+ Diffuse Large B-Cell Lymphoma in China

Lihong Gao, Hanxiao Zhu, Jia Wang, Yingtao Lin, Baolong Ding, Yuyang Sun, Tiantian Tao, Xin Li   +7 more
openalex   +2 more sources

Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Pemphigus vulgaris (PV) and foliaceus (PF) are rare autoimmune blistering diseases traditionally treated with systemic corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. Nonetheless, a subset of patients remains refractory or has contraindications to these conventional therapies.
José Javier Mateos Rico, Marta Gutiérrez Pascual, María Dolores Caro Gutiérrez, Cristina Marcos Rodríguez, Javier de Quadros Malagón, Francisco Javier Vicente Martín   +5 more
wiley   +1 more source

Pemphigus vegetans successfully treated with systemic corticosteroid and rituximab: a rare case report with 15-month follow-up and literature review. [PDF]

Front Immunol
Ji H, Chen L, Chen J.
europepmc   +1 more source

Diffuse large B‐cell lymphoma on the back of a patient with AIDS: Successful treatment by the CD20 monoclonal antibody rituximab [PDF]

, 2005
Constanze Voigtländer, Thomas Harrer, Lothar Schneider, Hendrik Schulze‐Koops, Gerald Niedobitek, Matthias Lüftl   +5 more
openalex   +1 more source

Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Alopecia areata (AA) is a chronic autoimmune hair loss disorder. Patients with primary autoimmune diseases commonly use systemic immunomodulators to manage disease and have an increased risk of developing AA. Systemic immunomodulators have diverse immunologic effects, but their impact on AA risk is not well understood. Objectives We
Angela Rose Liu, Nada Hentati, Bethany R. Rohr   +2 more
wiley   +1 more source

Efgartigimod combined with rituximab helps improve the symptoms and reduce the use of corticosteroids in patients with MuSK antibody-positive MG: a single case report. [PDF]

Front Immunol
Zheng X, Wang J, Cai T, Zhou H.
europepmc   +1 more source

Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis (PsO) and dermatomyositis (DM) are both autoimmune‐mediated, inflammatory conditions. The concurrence of PsO and DM is rare, and literature on their relationship remains limited. Additionally, cutaneous DM can be challenging to clinically diagnosis, often presenting with psoriasiform clinical features.
Emily R. Gordon, Karishma S. Shah, Sidharth Chand, Bonnie Lee, Janellen Smith, Michelle S. Min   +5 more
wiley   +1 more source